BDBM555966 3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)ethynyl]-1-[(3S,5R)-5-(methoxymethyl)-1-(prop-2-enoyl)pyrrolidin-3-yl]-5-(methylamino)pyrazole-4-carboxamide::US11345681, Example 135::US11345681, Example 167

SMILES CNc1c(C(N)=O)c(nn1[C@H]1C[C@H](COC)N(C1)C(=O)C=C)C#Cc1cc2ncn(C3CC3)c2cc1F

InChI Key InChIKey=AVUXLVYBASDKOX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 555966   

LigandPNGBDBM555966(3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of wild type FGFR1 (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 peptide as fluorogenic substrate incubated for 80 mins in presence of AT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM555966(3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: 3.30nMAssay Description:Inhibition of FGFR3 K650M mutant (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 peptide as fluorogenic substrate incubated for 80 mins in presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM555966(3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: 3.40nMAssay Description:Inhibition of wild type FGFR2 (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 peptide as fluorogenic substrate incubated for 80 mins in presence of AT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM555966(3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: 6.20nMAssay Description:Inhibition of FGFR2 V564F mutant (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 peptide as fluorogenic substrate incubated for 80 mins in presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM555966(3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: 9.40nMAssay Description:Inhibition of wild type FGFR3 (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 peptide as fluorogenic substrate incubated for 80 mins in presence of AT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM555966(3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: 13nMAssay Description:Inhibition of FGFR2 N549H mutant (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 peptide as fluorogenic substrate incubated for 80 mins in presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM555966(3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: 16nMAssay Description:Inhibition of FGFR3 V555M mutant (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 peptide as fluorogenic substrate incubated for 80 mins in presence of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM555966(3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

LigandPNGBDBM555966(3-[2-(1-Cyclopropyl-6-fluoro-1,3-benzodiazol-5-yl)...)
Affinity DataIC50: 100nMAssay Description:Small molecule inhibition of FGFR2 kinase activity was evaluated using a fluorescence-based microfluidic mobility shift assay. FGFR2 catalyzes the pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent